Hubei Dinglong CO.,Ltd. (300054.SZ) Bundle
Peeling back the numbers on Hubei Dinglong reveals a company in the midst of a strategic pivot: year-to-date revenue of CNY 2.698 billion for the first nine months of 2025 (TTM revenue CNY 3.61 billion), driven largely by a booming semiconductor materials arm that contributed about CNY 1.52 billion-a 40% year-on-year surge and roughly 57% of total sales-while printer consumables slipped amid weak demand; profitability shows momentum too, with net profit of CNY 519.42 million in 9M2025 (up 38% y/y), a TTM net margin near 14.4% and EPS rising to CNY 0.69, even as the balance sheet mixes conservative leverage (debt-to-equity ~0.47 on assets of CNY 4.5 billion) with strong liquidity (cash and equivalents of CNY 1.935 billion and a current ratio ~2.5), all priced into a market cap of CNY 35.37 billion with a trailing P/E of 54.10 and forward P/E of 46.16-metrics that underscore both investor optimism and the execution risks tied to aggressive semiconductor investments and softer consumables sales.
Hubei Dinglong CO.,Ltd. (300054.SZ) Revenue Analysis
In the first nine months of 2025 Hubei Dinglong reported revenue of CNY 2.698 billion, up 10.6% versus the same period in 2024. The company's growth is concentrated in the semiconductor materials segment, while the printer and copier consumables division showed softness.- Semiconductor materials: CNY 1.52 billion (≈40% YoY growth), ~57% of total sales in 9M2025.
- Printer & copier consumables: CNY 1.15 billion in 9M2025, modest decline due to sluggish market recovery and demand volatility.
- Revenue per employee (TTM/most recent): CNY 966,780 with 3,734 employees.
| Metric | Amount (CNY) | Period / Note | YoY Change |
|---|---|---|---|
| Revenue (First 9 months) | 2,698,000,000 | Jan-Sep 2025 | +10.6% |
| Semiconductor materials | 1,520,000,000 | 9M2025 - ~57% of sales | +40.0% |
| Printer & copier consumables | 1,150,000,000 | 9M2025 | Decline (small) |
| TTM Revenue | 3,610,000,000 | Trailing 12 months as of 2025-09-30 | +12.10% |
| Annual Revenue (2024) | 3,340,000,000 | FY2024 | +25.14% vs prior year |
| Employees | 3,734 | Reported headcount | - |
| Revenue per employee | 966,780 | TTM / recent | - |
- Segment mix shift: semiconductor materials now the primary revenue driver (57% share), supporting higher-margin exposure.
- Top-line momentum: TTM growth of 12.10% indicates sustained expansion beyond 9M results.
- Operational efficiency: revenue per employee (~CNY 966.8k) suggests relatively strong productivity for the workforce size.
Hubei Dinglong CO.,Ltd. (300054.SZ) - Profitability Metrics
Hubei Dinglong CO.,Ltd. delivered notable profit expansion through 2025, with improvements across margin and return measures that signal operational strength and efficient capital deployment.
- Net profit for the first nine months of 2025: CNY 519.42 million (up 38% vs. CNY 376.32 million in the same period of 2024).
- TTM net profit margin (as of 2025-09-30): ~14.4% - strong conversion of revenue into profit.
- TTM EPS (ending 2025-09-30): CNY 0.69, versus CNY 0.40 for the same period in 2024.
- Operating margin (TTM ending 2025-03-31): 21.34% - reflecting tight cost control and operational efficiency.
- ROA (TTM ending 2025-03-31): 6.13% - profitability from asset base.
- ROE (TTM ending 2025-03-31): 14.06% - effective use of shareholders' equity.
| Metric | Value | Period / Date | YoY / Comment |
|---|---|---|---|
| Net Profit (CNY) | 519.42 million | First 9 months 2025 | +38% vs. 1-9 2024 (376.32 million) |
| Net Profit Margin | 14.4% | TTM to 2025-09-30 | High margin for industrial/auto parts segment |
| EPS (CNY) | 0.69 | TTM to 2025-09-30 | 0.69 vs. 0.40 (TTM 2024) |
| Operating Margin | 21.34% | TTM to 2025-03-31 | Indicates operational efficiency |
| ROA | 6.13% | TTM to 2025-03-31 | Moderate asset productivity |
| ROE | 14.06% | TTM to 2025-03-31 | Solid shareholder returns |
For additional context on shareholder composition and recent investor activity, see: Exploring Hubei Dinglong CO.,Ltd. Investor Profile: Who's Buying and Why?
Hubei Dinglong CO.,Ltd. (300054.SZ) - Debt vs. Equity Structure
Hubei Dinglong CO.,Ltd. (300054.SZ) shows a capital structure as of June 30, 2025 that leans on a solid equity base while maintaining moderate financial leverage to support growth in semiconductors and advanced materials. Key balance-sheet and cash-flow metrics highlight the company's funding mix and recent deployment of capital.- Total assets: CNY 4.5 billion (June 30, 2025)
- Total liabilities: CNY 2.1 billion (June 30, 2025)
- Total equity: CNY 2.4 billion (June 30, 2025)
- Debt-to-equity ratio: ~0.47 (calculated: 2.1 / 2.4)
- Net cash outflow from investing activities in 2024: CNY 724.71 million
- Financial expenses (2024): CNY 6.14 million
| Metric | Value | Notes |
|---|---|---|
| Total Assets (30-Jun-2025) | CNY 4,500,000,000 | Company-wide consolidated assets |
| Total Liabilities (30-Jun-2025) | CNY 2,100,000,000 | Includes short- and long-term payables |
| Total Equity (30-Jun-2025) | CNY 2,400,000,000 | Shareholders' equity supporting operations |
| Debt-to-Equity Ratio | 0.47 | Moderate leverage (2.1 / 2.4) |
| Net Investing Cash Flow (2024) | -CNY 724,710,000 | Primarily acquisitions and capex |
| Major Acquisition (2024) | CNY 475,000,000 | 19% stake in Dinglong Microelectronics, raising holding to 91.35% |
| Financial Expenses (2024) | CNY 6,140,000 | Higher interest costs and lower FX gains |
- Acquisition-driven capital deployment: The CNY 475 million purchase to increase the Dinglong Microelectronics stake to 91.35% is the largest single use of 2024 investing cash and a driver of the negative investing cash flow.
- Leverage profile: With liabilities at CNY 2.1 billion versus equity of CNY 2.4 billion, the company maintains a debt-to-equity of ~0.47, indicating moderate reliance on debt financing.
- Interest and FX impact: Financial expenses rose to CNY 6.14 million due to increased interest on bank borrowings combined with reduced foreign-exchange gains, modestly pressuring net income.
- Strategic funding mix: The balance-sheet composition suggests Hubei Dinglong is using both equity and controlled leverage to fund semiconductor and advanced-material expansions.
Hubei Dinglong CO.,Ltd. (300054.SZ) - Liquidity and Solvency
As of June 30, 2025 Hubei Dinglong CO.,Ltd. (300054.SZ) demonstrates a solid short-term liquidity profile and conservative solvency metrics that support operational stability and strategic flexibility.- Cash and cash equivalents: CNY 1.935 billion, providing immediate coverage for short-term obligations.
- Current ratio: ~2.5, indicating that current assets are about 2.5 times current liabilities.
- Quick ratio: ~1.8, showing sufficient liquid assets excluding inventory to meet immediate liabilities.
- Net operating cash flow: CNY 198 million, down 27% year-on-year due to higher personnel expenses and increased taxes and fees.
- Debt-to-equity ratio: 0.47, reflecting a conservative leverage stance and lower financial risk.
| Metric | Value | Unit / Note |
|---|---|---|
| Cash & Cash Equivalents | 1,935,000,000 | CNY as of 2025-06-30 |
| Current Ratio | 2.5 | Current Assets / Current Liabilities |
| Quick Ratio | 1.8 | (Current Assets - Inventory) / Current Liabilities |
| Net Operating Cash Flow | 198,000,000 | CNY; -27% YoY |
| Debt-to-Equity Ratio | 0.47 | Total Debt / Total Equity |
- Strong cash balance plus a current ratio of 2.5 and quick ratio of 1.8 indicate ample short-term liquidity to cover payables and seasonal working capital needs.
- The 27% decline in operating cash flow to CNY 198 million signals near-term pressure on cash generation driven by higher personnel and tax-related outflows; continued monitoring of operating expenses is warranted.
- A debt-to-equity of 0.47 supports financial resilience, allowing room for selective borrowing to fund growth without materially increasing risk.
- Overall operational cash-generation capability remains intact, enabling the company to meet obligations and pursue investments when needed.
Hubei Dinglong CO.,Ltd. (300054.SZ) - Valuation Analysis
Hubei Dinglong CO.,Ltd. (300054.SZ) trades at a premium valuation profile driven by strong growth expectations in its semiconductor-related businesses and improved profitability metrics. As of December 12, 2025 the stock price and market metrics reflect investor optimism about sustained revenue and earnings expansion.- Stock price: CNY 37.35 (12-Dec-2025)
- Market capitalization: CNY 35.37 billion
- Trailing P/E: 54.10
- Forward P/E: 46.16
- Price-to-Sales (P/S): 8.92
- EV/Revenue (EV/R): 8.01
- EV/EBITDA: 29.58
- Projected earnings CAGR: 28.5% (company-specific)
- Chinese market earnings CAGR reference: 26.6%
| Metric | Value | Comment |
|---|---|---|
| Price (CNY) | 37.35 | Quote date: 2025-12-12 |
| Market Cap (CNY) | 35.37 billion | Equity market value |
| Trailing P/E | 54.10 | High multiple implies elevated expectations |
| Forward P/E | 46.16 | Discount to trailing P/E but still rich |
| P/S | 8.92 | Premium paid per unit revenue |
| EV/Revenue | 8.01 | Enterprise-level revenue multiple |
| EV/EBITDA | 29.58 | Reflects valuation relative to operating cash flow |
| Projected Earnings Growth (CAGR) | 28.5% | Outpaces Chinese market (26.6%) |
- High P/E (trailing and forward) signals strong future earnings expectations and limited margin for execution misses.
- Elevated P/S and EV/R indicate revenue is being valued at multiples well above many peers, reflecting strategic positioning in higher-growth segments.
- EV/EBITDA near 30 suggests market prices in robust profitability improvements; sensitivity to EBITDA swings is increased.
- Projected earnings CAGR of 28.5% vs. China market 26.6% explains much of the premium but requires continued execution to justify current price.
Hubei Dinglong CO.,Ltd. (300054.SZ) - Risk Factors
The following outlines the principal risk factors affecting Hubei Dinglong CO.,Ltd. (300054.SZ) financial health, supported by the latest reported figures and trends.- Printer and copier consumables division contraction: sales revenue declined 11.95% year‑on‑year to CNY 914 million, reflecting weaker market demand and supply‑chain pressures.
- Equity base erosion: net assets attributable to shareholders fell 6.50%, raising concerns about increased costs, provisions, or off‑balance liabilities that are reducing shareholder value.
- Rising finance costs: financial expenses increased materially to CNY 6.14 million, driven by lower foreign exchange gains and higher interest expenses from bank borrowings.
- Operating cash flow pressure: net operating cash flow decreased 27% year‑on‑year to CNY 198 million, primarily due to elevated personnel expenses and higher taxes & fees.
- Strategic execution and timing risk: aggressive expansion into the semiconductor sector exposes the company to potential delays in returns, steep upfront capital requirements, and intense market competition.
- Liquidity and leverage risk from investments: significant capital expenditures and acquisition activity may constrain short‑term liquidity and financial flexibility, increasing refinancing and interest rate risk.
| Metric | Reported Figure | Year‑on‑Year Change | Primary Driver |
|---|---|---|---|
| Printer & copier consumables sales | CNY 914 million | -11.95% | Demand decline; supply chain issues |
| Net assets attributable to shareholders | (Change) -6.50% | -6.50% | Higher expenses / possible provisions |
| Financial expenses | CNY 6.14 million | Significant increase | Lower FX gains; increased bank interest |
| Net operating cash flow | CNY 198 million | -27% | Higher personnel costs; taxes & fees |
| Capital deployment (acquisitions & CAPEX) | Significant (multiple projects) | - | Semiconductor expansion; strategic M&A |
- Operational sensitivities: any prolonged softness in core consumables demand or a deterioration in supply chains could further compress margins and operating cash flows.
- Funding and refinancing: elevated capex and M&A increases reliance on external funding; a rise in interest rates or tighter credit conditions would raise financing costs and pressure profitability.
- Execution risk in new business lines: semiconductor sector entry requires timely scale‑up, technology competitiveness, and market access - delays or missteps could produce prolonged negative cash impact.
- Foreign exchange and market volatility: reduced FX gains already contributed to higher finance costs; renewed currency volatility could further affect net finance expense and reported results.
Hubei Dinglong CO.,Ltd. (300054.SZ) - Growth Opportunities
The semiconductor materials segment is the primary engine driving Hubei Dinglong CO.,Ltd.'s near-term expansion, underpinned by robust CMP polishing-material sales, strategic equity moves, and a clear push toward high-end, import-substituting products.- CMP polishing materials sales: CNY 716 million in 2024, up 71.5% year-on-year, driven by orders from major domestic wafer fabs.
- Equity consolidation: Increased stake in Dinglong Microelectronics to 91.35% via acquisition of an additional 19% for CNY 475 million, strengthening control over upstream semiconductor capabilities.
- Earnings trajectory: Projected compound annual growth rate (CAGR) of 28.5%, outpacing the broader Chinese market CAGR of 26.6%-indicating above-market profit expansion.
- 2025 revenue guidance: Semiconductor materials revenue projected at CNY 1.52 billion for the first nine months of 2025 (≈ +40% YoY), expected to represent ~57% of total company sales.
| Metric | Value | Notes |
|---|---|---|
| CMP polishing materials sales (2024) | CNY 716 million | +71.5% YoY |
| Dinglong Microelectronics stake (post-acquisition) | 91.35% | Acquired additional 19% for CNY 475 million |
| Projected semiconductor materials revenue (9M 2025) | CNY 1.52 billion | ~40% YoY growth; ~57% of total sales |
| Projected earnings CAGR | 28.5% | Above Chinese market CAGR of 26.6% |
| Strategic focus | High-end semiconductor materials & import substitution | Targeting domestic wafer fab supply chains |
- Key growth levers:
- Ramping CMP product penetration at domestic fabs responding to localization policies.
- Vertical integration via increased ownership of Dinglong Microelectronics to secure IP, process know-how and gross-margin capture.
- Capex and R&D directed at high-end materials where import dependency is highest, creating premium pricing and market share opportunities.
- Commercial catalysts:
- Large orders from domestic wafer fabs supporting near-term revenue visibility.
- Growing share of semiconductor materials in total revenue (projected ~57% in 9M2025) improving overall margin profile.
- Strategic risks to monitor:
- Execution risk on scaling advanced-material production without quality or delivery failures.
- Price competition as domestic peers scale similar import-substitution initiatives.
- Capital deployment risk related to large M&A and R&D investments.

Hubei Dinglong CO.,Ltd. (300054.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.